Gap junction remodeling in skin repair following wounding and disease

Physiology

Volumn 28, Issue 3, 2013, Pages 190-198

  Churko, Jared M ^a   Laird, Dale W ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAP JUNCTION PROTEIN;

ANIMAL; CELL DIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; GAP JUNCTION; GENETIC PREDISPOSITION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; INJURY; METABOLISM; MUTATION; PATHOLOGY; PHENOTYPE; REVIEW; SIGNAL TRANSDUCTION; SKIN; SKIN DISEASE; WOUND HEALING;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CONNEXINS; GAP JUNCTIONS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; PHENOTYPE; SIGNAL TRANSDUCTION; SKIN; SKIN DISEASES; WOUND HEALING;

EID: 84878529977     PISSN: 15489213     EISSN: 15489221     Source Type: Journal    
DOI: 10.1152/physiol.00058.2012     Document Type: Review

References (78)

1. Alexander DB, Goldberg GS. Transfer of biologically important molecules between cells through gap junction channels. Curr Med Chem 10: 2045-2058, 2003.
2. Arita K, Akiyama M, Tsuji Y, McMillan JR, Eady RA, Shimizu H. Gap junction development in the human fetal hair follicle and bulge region. Br J Dermatol 150: 429-434, 2004.
3. Bajpai S, Shukla VK, Tripathi K, Srikrishna S, Singh RK. Targeting connexin 43 in diabetic wound healing: future perspectives. J Postgrad Med 55: 143-149, 2009.
4. Bakirtzis G, Choudhry R, Aasen T, Shore L, Brown K, Bryson S, Forrow S, Tetley L, Finbow M, Greenhalgh D, Hodgins M. Targeted epidermal expression of mutant Connexin 26(D66H) mimics true Vohwinkel syndrome and provides a model for the pathogenesis of dominant connexin disorders. Hum Mol Genet 12: 1737-1744, 2003.
5. Bakirtzis G, Jamieson S, Aasen T, Bryson S, Forrow S, Tetley L, Finbow M, Greenhalgh D, Hodgins M. The effects of a mutant connexin 26 on epidermal differentiation. Cell Commun Adhes 10: 359-364, 2003.
6. Brandner JM, Houdek P, Husing B, Kaiser C, Moll I. Connexins 26, 30, and 43: differences among spontaneous, chronic, and accelerated human wound healing. J Invest Dermatol 122: 1310-1320, 2004.
7. Brissette JL, Kumar NM, Gilula NB, Hall JE, Dotto GP. Switch in gap junction protein expression is associated with selective changes in junctional permeability during keratinocyte differentiation. Proc Natl Acad Sci USA 91: 6453-6457, 1994.
8. Butterweck A, Elfgang C, Willecke K, Traub O. Differential expression of the gap junction proteins connexin45,-43,-40,-31, and-26 in mouse skin. Eur J Cell Biol 65: 152-163, 1994.
9. Choudhry R, Pitts JD, Hodgins MB. Changing patterns of gap junctional intercellular communication and connexin distribution in mouse epidermis and hair follicles during embryonic development. Dev Dyn 210: 417-430, 1997.
10. Churko JM, Chan J, Shao Q, Laird DW. The G60S connexin43 mutant regulates hair growth and hair fiber morphology in a mouse model of human oculodentodigital dysplasia. J Invest Dermatol 131: 2197-2204, 2011.
11. Churko JM, Kelly JJ, Macdonald A, Lee J, Sampson J, Bai D, Laird DW. The G60S Cx43 mutant enhances keratinocyte proliferation and differentiation. Exp Dermatol 21: 612-618, 2012.
12. Churko JM, Langlois S, Pan X, Shao Q, Laird DW. The potency of the fs260 connexin43 mutant to impair keratinocyte differentiation is distinct from other disease-linked connexin43 mutants. Biochem J 429: 473-483, 2010.
13. Churko JM, Shao Q, Gong X, Swoboda KJ, Bai D, Sampson J, Laird DW. Human dermal fibroblasts derived from oculodentodigital dysplasia patients suggest that patients may have wound healing defects. Hum Mutat 32: 456-466, 2011.
14. Clouston HR. A hereditary ectodermal dystrophy. Can Med Assoc J 21: 18-31, 1929.
15. Coutinho P, Qiu C, Frank S, Tamber K, Becker D. Dynamic changes in connexin expression correlate with key events in the wound healing process. Cell Biol Int 27: 525-541, 2003.
16. Coutinho P, Qiu C, Frank S, Wang CM, Brown T, Green CR, Becker DL. Limiting burn extension by transient inhibition of connexin43 expression at the site of injury. Br J Plast Surg 58: 658-667, 2005.
17. Darby IA, Hewitson TD. Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol 257: 143-179, 2007.
18. de Zwart-Storm EA, Hamm H, Stoevesandt J, Steijlen PM, Martin PE, van GM, van Steensel MA. A novel missense mutation in GJB2 disturbs gap junction protein transport and causes focal palmoplantar keratoderma with deafness. J Med Genet 45: 161-166, 2008.
19. Djalilian AR, McGaughey D, Patel S, Seo EY, Yang C, Cheng J, Tomic M, Sinha S, Ishida-Yamamoto A, Segre JA. Connexin 26 regulates epidermal barrier and wound remodeling and promotes psoriasiform response. J Clin Invest 116: 1243-1253, 2006.
20. Ehrlich HP, Gabbiani G, Meda P. Cell coupling modulates the contraction of fibroblast-populated collagen lattices. J Cell Physiol 184: 86-92, 2000.
21. Essenfelder GM, Larderet G, Waksman G, Lamartine J. Gene structure and promoter analysis of the human GJB6 gene encoding connexin 30. Gene 350: 33-40, 2005.
22. Francis R, Xu X, Park H, Wei CJ, Chang S, Chatterjee B, Lo C. Connexin43 modulates cell polarity and directional cell migration by regulating microtubule dynamics. PLos One 6: e26379, 2011.
23. Ghatnekar GS, O'Quinn MP, Jourdan LJ, Gurjarpadhye AA, Draughn RL, Gourdie RG. Connexin43 carboxyl-terminal peptides reduce scar progenitor and promote regenerative healing following skin wounding. Regen Med 4: 205-223, 2009.
24. Gibson DF, Bikle DD, Harris J, Goldberg GS. The expression of the gap junctional protein Cx43 is restricted to proliferating and non differentiated normal and transformed keratinocytes. Exp Dermatol 6: 167-174, 1997.
25. Goliger JA, Paul DL. Expression of gap junction proteins Cx26, Cx31.1, Cx37, and Cx43 in developing and mature rat epidermis. Dev Dyn 200: 1-13, 1994.
26. Goliger JA, Paul DL. Wounding alters epidermal connexin expression and gap junction-mediated intercellular communication. Mol Biol Cell 6: 1491-1501, 1995.
27. Goodenough DA, Paul DL. Beyond the gap: functions of unpaired connexon channels. Nat Rev Mol Cell Biol 4: 285-294, 2003.
28. Haass NK, Wladykowski E, Kief S, Moll I, Brandner JM. Differential induction of connexins 26 and 30 in skin tumors and their adjacent epidermis. J Histochem Cytochem 54: 171-182, 2006.
29. Hervé JC, Bourmeyster N, Sarrouilhe D, Duffy HS. Gap junctional complexes: from partners to functions. Prog Biophys Mol Biol 94: 29-65, 2007.
30. Hill J, Paslin D, Wertz PW. A new covalently bound ceramide from human stratum corneumomega-hydroxyacylphytosphingosine. Int J Cosmet Sci 28: 225-230, 2006.
31. Hitomi K. Transglutaminases in skin epidermis. Eur J Dermatol 15: 313-319, 2005.
32. Houben E, De Paepe K, Rogiers V. A keratinocyte's course of life. Skin Pharmacol Physiol 20: 122-132, 2007.
33. Kamibayashi Y, Oyamada M, Oyamada Y, Mori M. Expression of gap junction proteins connexin 26 and 43 is modulated during differentiation of keratinocytes in newborn mouse epidermis. J Invest Dermatol 101: 773-778, 1993.
34. Kandyba EE, Hodgins MB, Martin PE. A murine living skin equivalent amenable to live-cell imaging: analysis of the roles of connexins in the epidermis. J Invest Dermatol 128: 1039-1049, 2008.
35. Kibschull M, Magin TM, Traub O, Winterhager E. Cx31 and Cx43 double-deficient mice reveal independent functions in murine placental and skin development. Dev Dyn 233: 853-863, 2005.
36. Kretz M, Euwens C, Hombach S, Eckardt D, Teubner B, Traub O, Willecke K, Ott T. Altered connexin expression and wound healing in the epidermis of connexin-deficient mice. J Cell Sci 116: 3443-3452, 2003.
37. Kretz M, Maass K, Willecke K. Expression and function of connexins in the epidermis, analyzed with transgenic mouse mutants. Eur J Cell Biol 83: 647-654, 2004.
38. Laird DW. Life cycle of connexins in health and disease. Biochem J 394: 527-543, 2006.
39. Laird DW, Puranam KL, Revel JP. Turnover and phosphorylation dynamics of connexin43 gap junction protein in cultured cardiac myocytes. Biochem J 273: 67-72, 1991.
40. Lampe PD, Nguyen BP, Gil S, Usui M, Olerud J, Takada Y, Carter WG. Cellular interaction of integrin alpha3beta1 with laminin 5 promotes gap junctional communication. J Cell Biol 143: 1735-1747, 1998.
41. Langevin HM, Cornbrooks CJ, Taatjes DJ. Fibroblasts form a body-wide cellular network. Histochem Cell Biol 122: 7-15, 2004.
42. Langlois S, Maher AC, Manias JL, Shao Q, Kidder GM, Laird DW. Connexin levels regulate keratinocyte differentiation in the epidermis. J Biol Chem 282: 30171-30180, 2007.
43. Larjava H, Salo T, Haapasalmi K, Kramer RH, Heino J. Expression of integrins and basement membrane components by wound keratinocytes. J Clin Invest 92: 1425-1435, 1993.
44. Lemaître G, Sivan V, Lamartine J, Cosset JM, Cavelier-Balloy B, Salomon D, Waksman G, Martin MT. Connexin 30, a new marker of hyperproliferative epidermis. Br J Dermatol 155: 844-846, 2006.
45. Lucke T, Choudhry R, Thom R, Selmer IS, Burden AD, Hodgins MB. Upregulation of connexin 26 is a feature of keratinocyte differentiation in hyperproliferative epidermis, vaginal epithelium, and buccal epithelium. J Invest Dermatol 112: 354-361, 1999.
46. Maestrini E, Korge BP, Ocaña-Sierra J, Calzolari E, Cambiaghi S, Scudder PM, Hovnanian A, Monaco AP, Munro CS. A missense mutation in connexin26, D66H, causes mutilating keratoderma with sensorineural deafness (Vohwinkel's syndrome) in three unrelated families. Hum Mol Genet 8: 1237-1243, 1999.
47. Makowski L, Caspar DL, Phillips WC, Goodenough DA. Gap junction structures. V. Structural chemistry inferred from X-ray diffraction measurements on sucrose accessibility and trypsin susceptibility. J Mol Biol 174: 449-481, 1984.
48. Man YK, Trolove C, Tattersall D, Thomas AC, Papakonstantinopoulou A, Patel D, Scott C, Chong J, Jagger DJ, O'Toole EA, Navsaria H, Curtis MA, Kelsell DP. A deafness-associated mutant human connexin 26 improves the epithelial barrier in vitro. J Membr Biol 218: 29-37, 2007.
49. Marquez-Rosado L, Singh D, Rincon-Arano H, Solan JL, Lampe PD. CASK (LIN2) interacts with Cx43 in wounded skin and their coexpression affects cell migration. J Cell Sci 125: 695-702, 2012.
50. Matic M, Evans WH, Brink PR, Simon M. Epidermal stem cells do not communicate through gap junctions. J Invest Dermatol 118: 110-116, 2002.
51. Mori R, Power KT, Wang CM, Martin P, Becker DL. Acute downregulation of connexin43 at wound sites leads to a reduced inflammatory response, enhanced keratinocyte proliferation and wound fibroblast migration. J Cell Sci 119: 5193-5203, 2006.
52. O'Toole EA, Marinkovich MP, Hoeffler WK, Furthmayr H, Woodley DT. Laminin-5 inhibits human keratinocyte migration. Exp Cell Res 233: 330-339, 1997.
53. Ormonde S, Chou CY, Goold L, Petsoglou C, Al-Taie R, Sherwin T, McGhee CN, Green CR. Regulation of connexin43 gap junction protein triggers vascular recovery and healing in human ocular persistent epithelial defect wounds. J Membr Biol 245: 381-388, 2012.
54. Plum A, Winterhager E, Pesch J, Lautermann J, Hallas G, Rosentreter B, Traub O, Herberhold C, Willecke K. Connexin31-deficiency in mice causes transient placental dysmorphogenesis but does not impair hearing and skin differentiation. Dev Biol 231: 334-347, 2001.
55. Pollok S, Pfeiffer AC, Lobmann R, Wright CS, Moll I, Martin PE, Brandner JM. Connexin 43 mimetic peptide Gap27 reveals potential differences in the role of Cx43 in wound repair between diabetic and non-diabetic cells. J Cell Mol Med 15: 861-873, 2011.
56. Prochnow N, Dermietzel R. Connexons and cell adhesion: a romantic phase. Histochem Cell Biol 130: 71-77, 2008.
57. Qiu C, Coutinho P, Frank S, Franke S, Law LY, Martin P, Green CR, Becker DL. Targeting connexin43 expression accelerates the rate of wound repair. Curr Biol 13: 1697-1703, 2003.
58. Reaume AG, de Sousa PA, Kulkarni S, Langille BL, Zhu D, Davies TC, Juneja SC, Kidder GM, Rossant J. Cardiac malformation in neonatal mice lacking connexin43. Science 267: 1831-1834, 1995.
59. Richard G. Connexins: a connection with the skin. Exp Dermatol 9: 77-96, 2000.
60. Richard G, Smith LE, Bailey RA, Itin P, Hohl D, Epstein EH Jr, DiGiovanna JJ, Compton JG, Bale SJ. Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis. Nat Genet 20: 366-369, 1998.
61. Richards TS, Dunn CA, Carter WG, Usui ML, Olerud JE, Lampe PD. Protein kinase C spatially and temporally regulates gap junctional communication during human wound repair via phosphorylation of connexin43 on serine368. J Cell Biol 167: 555-562, 2004.
62. Risek B, Klier FG, Gilula NB. Multiple gap junction genes are utilized during rat skin and hair development. Development 116: 639-651, 1992.
63. Roscoe W, Veitch GI, Gong XQ, Pellegrino E, Bai D, McLachlan E, Shao Q, Kidder GM, Laird DW. Oculodentodigital dysplasia-causing connexin43 mutants are non-functional and exhibit dominant effects on wild-type connexin43. J Biol Chem 280: 11458-11466, 2005.
64. Rouan F, White TW, Brown N, Taylor AM, Lucke TW, Paul DL, Munro CS, Uitto J, Hodgins MB, Richard G. Trans-dominant inhibition of connexin-43 by mutant connexin-26: implications for dominant connexin disorders affecting epidermal differentiation. J Cell Sci 114: 2105-2113, 2001.
65. Salomon D, Masgrau E, Vischer S, Ullrich S, Dupont E, Sappino P, Saurat JH, Meda P. Topography of mammalian connexins in human skin. J Invest Dermatol 103: 240-247, 1994.
66. Schnichels M, Wörsdörfer P, Dobrowolski R, Markopoulos C, Kretz M, Schwarz G, Winterhager E, Willecke K. The connexin31 F137L mutant mouse as a model for the human skin disease erythrokeratodermia variabilis (EKV). Hum Mol Genet 16: 1216-1224, 2007.
67. Schütz M, Auth T, Gehrt A, Bosen F, Körber I, Strenzke N, Moser T, Willecke K. The connexin26 S17F mouse mutant represents a model for the human hereditary keratitis-ichthyosis-deafness syndrome. Hum Mol Genet 20: 28-39, 2011.
68. Smith F. The molecular genetics of keratin disorders. Am J Clin Dermatol 4: 347-364, 2003.
69. Söhl G, Willecke K. Gap junctions and the connexin protein family. Cardiovasc Res 62: 228-232, 2004.
70. Strober BE. Erythrokeratodermia variabilis. Dermatol Online J 9: 5, 2003.
71. van Steensel MA, Spruijt L, van dBI, Bladergroen RS, Vermeer M, Steijlen PM, van GM. A 2-bp deletion in the GJA1 gene is associated with oculo-dento-digital dysplasia with palmoplantar keratoderma. Am J Med Genet A 132A: 171-174, 2005.
72. Vreeburg M, de Zwart-Storm EA, Schouten MI, Nellen RG, Marcus-Soekarman D, Devies M, van Geel M, van Steensel MA. Skin changes in oculodento-digital dysplasia are correlated with C-terminal truncations of connexin 43. Am J Med Genet 143: 360-363, 2007.
73. Wang CM, Lincoln J, Cook JE, Becker DL. Abnormal connexin expression underlies delayed wound healing in diabetic skin. Diabetes 56: 2809-2817, 2007.
74. Wiszniewski L, Limat A, Saurat JH, Meda P, Salomon D. Differential expression of connexins during stratification of human keratinocytes. J Invest Dermatol 115: 278-285, 2000.
75. Wright CS, Berends RF, Flint DJ, Martin PE. Cell motility in models of wounded human skin is improved by Gap27 despite raised glucose, insulin and IGFBP-5. Exp Cell Res 319: 390-401, 2013.
76. Wright CS, van Steensel MA, Hodgins MB, Martin PE. Connexin mimetic peptides improve cell migration rates of human epidermal keratinocytes and dermal fibroblasts in vitro. Wound Repair Regen 17: 240-249, 2009.
77. Yamakage K, Omori Y, Piccoli C, Yamasaki H. Growth control of 3T3 fibroblast cell lines established from connexin 43-deficient mice. Mol Carcinog 23: 121-128, 1998.
78. Zhang Y, Kanter EM, Laing JG, Aprhys C, Johns DC, Kardami E, Yamada KA. Connexin43 expression levels influence intercellular coupling and cell proliferation of native murine cardiac fibroblasts. Cell Commun Adhes 15: 289-303, 2008.